Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases.

Kander MC, Cui Y, Liu Z. · 2017

Read Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. by Kander MC, Cui Y, Liu Z. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5387169.txt.

Introduction

Melissa Christine Kander, Yuqi Cui, and Zhenguo Liu review sex differences in oxidative stress and heart disease in a 2017 paper in the Journal of Cellular and Molecular Medicine. Oxidative stress means harm from reactive oxygen forms that the body fails to clear. Men tend to have heart attacks earlier than women, and a woman's risk rises after menopause, which hints that estrogen guards the heart.

Hormone treatment after menopause did not cut risk, so other paths must matter. Women seem less prone to this stress under normal states, perhaps due to estrogen's guarding action or to sex differences in a key enzyme that makes reactive oxygen. The authors sort the proof by disease and weigh the likely causes.

Catalog record

CREATORKander MC, Cui Y, Liu Z.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5387169

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases By Melissa Christine Kander, Yuqi Cui, Zhenguo Liu Published in: Journal of Cellular and Molecular Medicine DOI: 10.1111/jcmm.13038 ABSTRACT Abstract Gender differences are present in many diseases and are especially prevalent in cardiovascular disease. Males tend to suffer from myocardial infarctions earlier than females, and a woman's risk of cardiovascular disease increases after menopause, suggesting a cardio‐protective role of estrogen. However, hormone replacement therapy did not decrease the risk of cardiovascular disease in post‐menopausal women; thus, other mechanisms may be involved besides estrogen. Oxidative stress plays an important role in the development of cardiovascular diseases such as coronary artery disease. Gender is also associated with differences in oxidative stress. Under physiological conditions, females appear to be less susceptible to oxidative stress. This may be due to the antioxidant properties of estrogen, gender differences in NADPH‐oxidase activity or other mechanism(s) yet to be defined. This review strives to discuss gender differences in general terms followed by a more detailed examination of gender differences with oxidative stress and various associated diseases and the possible mechanisms underlying these differences. Keywords: gender, oxidative stress, cardiovascular disease INTRODUCTION Differences between males and females can be seen in many diseases such as coronary artery disease (CAD). The prevalence, presentation, severity and outcome for a variety of diseases have been known to vary based on gender. One example is Alzheimer's disease, which disproportionally affects women more than men in both prevalence and severity 1. Multiple sclerosis (MS) also has a higher prevalence in women than in men, and the female‐to‐male ratio of patients with MS has been increasing over the past several decades 2. However, not all diseases affect women more than men like Alzheimer's disease, and MS. Parkinson's disease presents with a more benign phenotype in women and the incidence of the disease is also lower in women 3. Besides these medical conditions mentioned here, there are many other diseases displaying gender differences. These differences are important because it is possible that different therapies and treatments could be targeted for men and women. Cardiovascular diseases are one of the areas in particular where gender differences have been studied extensively. In this review, the general gender differences in cardiovascular diseases will be discussed. Then, more specifically, gender differences in oxidative stress will be examined. Oxidative stress is considered an important mechanism for the development of cardiovascular diseases especially atherosclerosis 4, 5. Because gender differences in cardiovascular diseases are prevalent, it is important to study the link between gender differences in oxidative stress, which will be the focus of this review, although oxidative stress associated with other disease states will also be discussed briefly. GENDER DIFFERENCES IN CARDIOVASCULAR DISEASES Gender differences have been observed and studied in a wide range of cardiovascular diseases, including myocardial infarctions (MI), heart failure, hypertension, shock, cardiac hypertrophy, as well as other diseases involving the cardiovascular system as summarized in Table 1. Some of these differences have been so pronounced in animal studies that researchers have suggested that at some level, male and female hearts are functionally distinct from one another 6. These differences stem from the observation that pre‐menopausal women are relatively protected from cardiovascular diseases when compared to men possibly due to cardio‐protective effects of estrogen 6. The role of estrogen will be discussed more extensively in a later section of the review. [Table: Gender differences in cardiovascular diseases and risk factors] Gender differences have been seen in MI. Typically women are older than men when they have their first MI 6. In fact, women who present with a ST‐elevation MI (STEMI) are almost 10 years older than men 7. Although often older than men, the younger a woman is when she has her first MI, the greater her risk of death compared to an age‐matched male 6. One study with younger patients of 30–54 years of age showed that women represented 25% of hospitalizations for acute MI yet these patients had higher incidence of in‐hospital mortality compared to males 8. These data indicate that pre‐menopausal women are less likely to have a MI compared to males of the same age, but are more likely to suffer from comorbidities or more severe MI resulting in a higher mortality. The high mortality rate in females did decrease significantly over the 10‐year period, while the mortality rate in males did not change significantly 8. In addition to the age of presentation and severity, women are more likely than men to present with atypical MI symptoms. Women are more likely than men to present without chest pain 9. Women are also less likely to have anatomical obstructive CAD than men, but are more likely to present with myocardial ischaemia and thus ischaemic heart disease 10. Gender variation also can be seen in patients with heart failure. The incidence of heart failure is higher in men than in women 6. The prevalence of heart failure is about the same for both males and females 6. This is because even though more males are diagnosed with heart failure, the number of males and females living with heart failure is similar as women with heart failure usually have a lower mortality rate than men. There is also a difference in the most common type of heart failure in men and women: diastolic heart failure occurs more often in women, whereas systolic heart failure occurs more often in men 6. Hypertension, cardiac hypertrophy and ischaemia–reperfusion injury are three other major cardiovascular conditions where gender differences are present. Young adult women are less likely to develop hypertension than men 11. Also, animal studies have shown that males develop an earlier and more severe hypertension than females 12, 13, 14. Males are also shown to have increased cardiac hypertrophy compared to females 15, 16 (Fig. 1A). Females are also more likely to have relatively preserved left ventricular function 10. In addition to reduced hypertrophy, studies have also shown that females have reduced ischaemia–reperfusion injury 15, 17 (Fig. 1B). The beneficial outcome in ischaemia–reperfusion injury in females may be due to the effect of estrogen. Elevated calcium levels increase ischaemia–reperfusion injury, and estrogen may lower the calcium levels before ischaemia leading to less injury in females 15. [Figure: Male and female differences in hypertrophy and ischaemia–reperfusion injury. (A) In an animal study with mice, females were shown to have lower levels of hypertrophy than males. Figure adapted from Skavdahl et al. 16. (B) In a global ischaemia model of rat hearts, females were shown to have a smaller percentage of infarct than males. Figure adapted from Bae and Zhang 17.] In addition to cardiovascular diseases themselves, there is also a link between several cardiovascular disease risk factors and gender. Of the many cardiovascular disease risk factors, diabetes, high‐density lipoprotein (HDL) levels and triglyceride levels have more of an impact on cardiovascular disease risk in women than in men 18. Diabetic men for example have a two‐ to threefold increased risk of developing CAD, whereas a diabetic woman has a three‐ to sevenfold increased risk 18, 19 (Fig. 2A). Thus, diabetic women have an even higher risk of developing heart disease compared to diabetic men. High‐density lipoprotein levels

Read the complete text